We noted you are experiencing viewing problems
- 
        
        Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
 - 
        
        Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. - 
        
        No luck yet? More tips for troubleshooting viewing issues
 - 
        
        Contact HST Support access@hstalks.com
 
- 
        Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
 - 
        For additional help, please don't hesitate to contact HST support access@hstalks.com
 
We hope you have enjoyed this limited-length demo
                    
                    This is a limited length demo talk; you may
                    
                      login or
                    
                    review methods of
                    obtaining more access.
                  
                
                
              Printable Handouts
Navigable Slide Index
Topics Covered
- Characteristic of Streptococcus agalactia
 - Pathogenesis
 - Epidemiology and risk factors
 - Pregnant woman and Streptococcus agalactia
 - Virulence factors
 - Prevention and treatment
 
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Fouch, S. (2024, October 31). Streptococcus agalactiae [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 4, 2025, from https://doi.org/10.69645/CNIP4704.Export Citation (RIS)
Publication History
- Published on October 31, 2024
 
Financial Disclosures
- Dr. Sarah Fouch has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
 
Other Talks in the Series: Introduction to Microbes
Transcript
Please wait while the transcript is being prepared...
      
      
        
                  0:00
                
                
                  
                    Hello, everyone. My name
is Dr. Sarah Fouch.
                  
                    Welcome to this short
recording where we
                  
                    will be considering
group B streptococci.
                  
                    We will think about the
clinical conditions that
                  
                    this organism is associated
with, and we will
                  
                    also think about the
virulence factors that help
                  
                    this organism to be
                  
                    associated with the
clinical conditions.
                  
                
              
                  0:26
                
                
                  
                    Let's think about
group B streptococci,
                  
                    and these are gram
positive cocci.
                  
                    We will isolate
them on blood agar
                  
                    because they require a
nutritionally rich media,
                  
                    and when they grow,
                  
                    they will appear as
buttery-like colonies.
                  
                    When we compare the
haemolysis patterns
                  
                    between group A and
group B streptococci,
                  
                    both of these organisms produce
                  
                    beta-haemolysis so we will
                  
                    have complete haemolysis
of the red blood cells.
                  
                    But group A
streptococci will have
                  
                    quite a large zone
of haemolysis.
                  
                    In comparison, group B has
                  
                    quite a small zone
of beta-haemolysis.
                  
                    We are able to type group B
streptococci and we will use
                  
                    the group-specific antigens
                  
                    that are expressed
on the cell wall.
                  
                    Again, we can do this
                  
                    through grouping
agglutination investigations.
                  
                    There are 10 serotypes of
                  
                    group B streptococci based
                  
                    on their capsular
polysaccharides.
                  
                    But the interesting thing about
                  
                    group B streptococci is
                  
                    although it has a range
of virulence factors,
                  
                    it doesn't tend to cause
                  
                    as many infections in comparison
to group A streptococci.
                  
                    When we think about the enzymes
                  
                    that this organism can produce,
                  
                    we can use various enzymes
for identification.
                  
                    But again, the group
B streptococci
                  
                    does not tend to
use the enzymes for
                  
                    pathogenesis because
we do not see
                  
                    many of these in quite
nasty infections.
                  
                    When we think about
group B streptococci,
                  
                    as with other organisms,
                  
                    there are areas of
the body where we
                  
                    will find this as normal flora.
                  
                    We tend to find group B
streptococci colonising
                  
                    our lower
gastrointestinal system
                  
                    and also our genital
urinary system.